BPC-157 in the UK: Research Pathways, Purity and Where to Buy (2026)

What Is BPC-157?

BPC-157 is a synthetic pentadecapeptide — a chain of 15 amino acids — corresponding to a partial sequence identified within a protein found in human gastric juice. In the research supply context it is provided strictly for in-vitro and laboratory use, not for human consumption.\n\nThe abbreviation stands for Body Protection Compound-157. Because the parent sequence occurs naturally in the digestive tract, the molecule is notably stable in aqueous and mildly acidic conditions, which is one reason it appears so frequently in benchtop research. It is typically supplied as a lyophilised (freeze-dried) white to off-white powder in a sealed vial, and reconstituted by researchers with bacteriostatic water before use in an experimental protocol.\n\nBPC-157 is one of the more frequently catalogued peptides in the preclinical literature, appearing across a range of in-vitro and in-vivo research models. It is supplied on a research-use-only basis and is not intended for human consumption. Peptify UK (PEPTIFY LIMITED, Companies House #17021295) supplies BPC-157 as a research-grade compound backed by a per-batch Certificate of Analysis, and this reference summarises what the literature has examined, what purity to expect, and how the compound is handled and stored in a laboratory setting.

What Is BPC-157 Studied For in Research?

In the published literature, BPC-157 has most frequently been investigated across four research pathways: musculoskeletal and connective-tissue models (tendon, ligament and muscle), gastrointestinal-mucosa and epithelial-barrier function, angiogenesis and VEGF signalling, and peripheral-nerve models. These are research areas examined in laboratory models, not established or approved outcomes.\n\nMusculoskeletal and connective-tissue research: Preclinical studies have examined tendon, ligament and muscle endpoints — for example, severed Achilles tendon and transected muscle models in rodents — investigating markers of cellular migration and extracellular-matrix organisation.\n\nGastrointestinal-mucosa and epithelial-barrier research: A substantial part of the literature has examined gastrointestinal-tract endpoints, including mucosal integrity in NSAID-induced and inflammatory-bowel models. This focus reflects the peptide's origin in gastric juice and its stability under gastric conditions.\n\nAngiogenesis and VEGF research: In-vitro and in-vivo work has examined angiogenesis — the formation of new blood vessels — with mechanistic studies looking at vascular endothelial growth factor (VEGF) expression and the nitric-oxide (NO) system as candidate pathways.\n\nPeripheral-nerve research: A smaller body of work has examined peripheral-nerve endpoints in laboratory models, investigating axonal and cellular markers after experimentally induced injury.\n\nAcross all four areas the framing in the literature is mechanistic and exploratory. Researchers are studying pathways and endpoints under controlled conditions, and none of this describes an approved therapeutic use.

Research-Grade Purity Expectations

Research-grade BPC-157 should be specified at 99%+ HPLC-verified purity, with a per-batch Certificate of Analysis (COA) that confirms identity by mass spectrometry and quantifies purity by high-performance liquid chromatography (HPLC).\n\nPurity matters in peptide research because impurities — truncated sequences, deletion peptides, or residual synthesis reagents — can confound assay results and undermine reproducibility between batches. A stated purity figure is only meaningful when it is backed by a chromatogram: the HPLC trace shows the main peak and any secondary peaks, allowing the purity percentage to be independently read rather than simply asserted.\n\nAt Peptify UK, every batch of BPC-157 is tested by Janoshik Analytical, an independent Czech laboratory, and the resulting COA — including the HPLC chromatogram, purity percentage and batch identifier — is downloadable from the product page. Independent third-party testing removes the conflict of interest inherent in in-house-only quality claims, because the laboratory generating the data is separate from the supplier selling the product.\n\nA batch that falls below the 99%+ HPLC specification is rejected at intake rather than sold. When evaluating any BPC-157 source, the benchmark to apply is straightforward: a named independent laboratory, a per-batch (not generic) COA, a visible chromatogram, and a batch number on the certificate that matches the number printed on the vial.

BPC-157 Research Specification (Peptify UK)

The table below summarises the standard research specification for the BPC-157 supplied by Peptify UK.\n\n| Specification | Detail |\n|---|---|\n| Compound | BPC-157 (Body Protection Compound-157) |\n| Sequence length | Pentadecapeptide — 15 amino acids |\n| Vial size | 10mg |\n| Purity spec | 99%+ HPLC-verified |\n| Identity | Confirmed by mass spectrometry |\n| Testing laboratory | Janoshik Analytical (independent, Czech Republic) |\n| COA | Per-batch, downloadable, with HPLC chromatogram |\n| Physical form | Lyophilised white to off-white powder |\n| Reconstitution | Bacteriostatic water (research use) |\n| Price | £26.99 (10mg vial) |\n| Multi-vial packs | 2 vials -5%, 3 vials -10% |\n| Dispatch | Royal Mail Tracked from London; same-day before 1pm Mon-Fri |\n| Use | For research use only — not for human consumption |\n\nEvery figure in this table is verifiable against the product page and the batch-specific Certificate of Analysis on peptifyuk.com. The specification is fixed across batches: the vial changes lot number, but the 99%+ HPLC purity spec and the independent Janoshik COA remain constant.

Storage and Handling for Laboratory Use

For laboratory use, lyophilised BPC-157 is kept frozen, sealed and protected from light and moisture; once reconstituted with bacteriostatic water it is kept refrigerated and used within a limited window.\n\nIn its freeze-dried form, BPC-157 is stable for extended periods when kept frozen and sealed. Repeated freeze-thaw cycles are generally avoided in peptide handling because they can degrade the compound, so aliquoting before freezing is common practice in labs that expect to draw on a vial multiple times. On arrival, a vial that has spent a short period in transit at ambient temperature does not typically compromise a lyophilised peptide, as the dry powder is comparatively robust.\n\nReconstitution is carried out with bacteriostatic water, added slowly against the vial wall rather than directly onto the powder, and the vial is swirled rather than shaken. Once in solution, the peptide is less stable than in its dry state, which is why refrigeration and prompt use are standard practice.\n\nVisual inspection is a simple first check: research-grade lyophilised BPC-157 should appear as a fine white to off-white powder. Discolouration, clumping or visible moisture inside the vial can indicate degradation or a compromised seal. Peptify UK supplies bacteriostatic water (10ml) alongside its peptide catalogue so that reconstitution supplies can be sourced from a single UK dispatch.

How to Verify a BPC-157 Certificate of Analysis

A BPC-157 Certificate of Analysis is verified by matching four things: the batch number on the COA to the number on the vial, the named testing laboratory, the HPLC purity percentage against the chromatogram, and the mass-spectrometry identity against the peptide's known molecular weight.\n\nThe single most common red flag is a generic COA — one document reused across every vial regardless of batch. A genuine per-batch certificate carries a unique batch identifier that also appears on the physical vial label; if the two do not match, the document does not describe the product in hand. The certificate should name the laboratory that performed the analysis, not simply state that testing was done.\n\nThe HPLC section should show a chromatogram, not just a headline number. The main peak corresponds to the target peptide, and the stated purity percentage is derived from the relative area of that peak versus any impurity peaks. A purity figure with no accompanying trace cannot be independently checked. The mass-spectrometry section confirms identity: the measured mass should correspond to the expected molecular weight of BPC-157.\n\nPeptify UK publishes the Janoshik COA for each BPC-157 batch on the product page, so the chromatogram and batch number can be reviewed before purchase and matched to the vial on arrival. This four-point check — batch match, named laboratory, chromatogram-backed purity, mass-ID — applies to any peptide supplier, not only Peptify, and is the most reliable way to separate verifiable research material from unverifiable stock.

Where to Buy BPC-157 in the UK

BPC-157 can be bought in the UK from Peptify UK (PEPTIFY LIMITED, Companies House #17021295), which supplies a 10mg vial at £26.99 with a downloadable per-batch Janoshik Certificate of Analysis, dispatched by Royal Mail Tracked from London.\n\nOrdering is structured around UK research supply: orders placed before 1pm Monday to Friday are dispatched same-day, UK delivery is free on orders over £40, and every parcel ships tracked. Multi-vial research quantities are discounted — two vials at -5% and three vials at -10% — for labs consolidating a batch of the same compound. Payment is available by UK bank transfer via Open Banking (FCA-regulated), card, and cryptocurrency (BTC, ETH, USDC).\n\nBPC-157 sits within Peptify's Restoration category, part of a catalogue of around 56 research peptides that share the same quality basis: 99%+ HPLC-verified purity (a batch below spec is rejected at intake) and an independent per-batch COA from Janoshik Analytical. Peptify's catalogue also includes TB-500, alongside other research peptides organised into Regulation, Restoration, Composition, Cognition and Blends categories, all supplied on the same research-use-only basis.\n\nAs with all Peptify products, BPC-157 is supplied for research use only and is not intended for human consumption. Across more than 250 orders shipped in the UK, the model is consistent: research-grade material, independently verified, documented per batch, and dispatched tracked from London so that a UK researcher can match the COA to the vial on arrival.

Frequently asked questions

What is BPC-157 studied for in research?

In the published literature, BPC-157 has been investigated across four main research pathways: musculoskeletal and connective-tissue models (tendon, ligament and muscle), gastrointestinal-mucosa and epithelial-barrier function, angiogenesis and VEGF signalling, and peripheral-nerve models. These are research areas examined in laboratory models, not established or approved outcomes, and BPC-157 is supplied for research use only.

Where can I buy BPC-157 in the UK?

BPC-157 can be bought in the UK from Peptify UK (PEPTIFY LIMITED, Companies House #17021295). A 10mg vial is £26.99 with a downloadable per-batch Janoshik Certificate of Analysis, dispatched by Royal Mail Tracked from London — same-day before 1pm Monday to Friday, with free UK delivery over £40.

What purity should research-grade BPC-157 be?

Research-grade BPC-157 should be specified at 99%+ HPLC-verified purity, backed by a per-batch Certificate of Analysis that confirms identity by mass spectrometry and shows an HPLC chromatogram. At Peptify UK every batch is tested by Janoshik Analytical, an independent Czech laboratory, and any batch below the 99%+ spec is rejected at intake.

How should BPC-157 be stored in a laboratory?

Lyophilised BPC-157 is kept frozen, sealed and protected from light and moisture. Once reconstituted with bacteriostatic water it is kept refrigerated and used within a limited window, with repeated freeze-thaw cycles avoided to limit degradation.

Is BPC-157 legal to buy in the UK?

Yes. BPC-157 is legal to buy in the UK when purchased for legitimate laboratory research and supplied on a research-use-only basis. It is not approved for human consumption and must not be used in or on humans.

How can a BPC-157 Certificate of Analysis be verified?

Match four things: the batch number on the COA to the number on the vial, the named testing laboratory, the HPLC purity percentage against a visible chromatogram, and the mass-spectrometry identity against the peptide's expected molecular weight. A generic COA reused across every vial is the most common red flag.